A Prospective, Multicenter Registry to Observe the Treatment Patterns, Clinical Outcomes, and Decision-Making in Patients With Early Breast Cancer Eligible for EndoPredict® Testing

ConditionsBreast Cancer Breast Adenocarcinoma

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorNational and Kapodistrian University of Athens

About this trial

The study is planned to observe and document the therapeutic decision-making process, treatment protocols, and clinical outcomes in patients with luminal breast cancer, whether they have undergone EndoPredict® testing or not

Eligibility criteria

Qualifiers

Age ≥ 18 years old.

Histological diagnosis of invasive breast cancer.

T1-T3 tumor size.

0-3 positive axillary lymph nodes.

Disqualifiers

History of another primary malignancy within the last 5 years, except for resected non-melanoma skin cancer.

Pre-operative chemotherapy administered.

Subject without signed and dated informed consent form.

Trial design

Treatments tested in this trial

Not listed

Trial groups

2,000 Participants

are grouped into 1 trial group

Locations13

Select a site below to view it on the map.

Sponsors and collaborators

National and Kapodistrian University of Athens

Lead sponsor

Source ClinicalTrials.gov